| Jul 2, 2012
| 10:01 AM
Attorney General Linda Kelly today announced that Pennsylvania will receive more than $13 million as part of the largest healthcare fraud settlement in United States history.
Kelly said that GlaxoSmithKline, a British based pharmaceutical company that...
| Jul 2, 2012
| 10:35 AM
Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...
| Jul 6, 2012
| 8:29 AM
LOS ANGELES (KTLA) -- Celebrity addiction specialist Dr. Drew Pinsky is under fire for helping market an antidepressant for uses not approved by the Food and Drug Administration.
GlaxoSmithKline, which makes the drug Wellbutrin, agreed to pay a $3...
| Jul 16, 2012
| 4:00 PM
After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
GlaxoSmithKline boosted its offer for...
| Jul 16, 2012
| 8:54 PM
For years people around the country have been climbing mountains for CureDuchenne.
As they raise money and awareness, they also get younger.
Most recently, 8-year-old Tyler Armstrong climbed Mt. Kilimanjaro and helped raise about $40,000 for the Newport...
| Jul 18, 2012
| 11:43 AM
LOS ANGELES/GENEVA (Reuters) - Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday.
The United Nations...
| Aug 10, 2012
Shengyang Zhou assured the American buyers that his Chinese-made weight-loss capsules were safe. Zhou was sure because he had a test — one person eats a whole bottle.
Such a person would have "maybe some stomach problem, but not die," he told...
| Apr 19, 2012
| 5:40 PM
Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low.
Human Genome, which uses the human DNA...
| Apr 21, 2012
| 11:26 AM
Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals.
Both homegrown companies — Human Genome Sciences Inc. and Catalyst...
| Mar 19, 2013
Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines.
Today, as the world confronts the crisis of antibiotic resistance, the industry...
| Feb 20, 2013
| 3:50 PM
Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market.
The company also withheld data that showed the drugs...